- Case report
- Open Access
Streptococcus acidominimus causing invasive disease in humans: a case series
Journal of Medical Case Reports volume 8, Article number: 57 (2014)
Streptococcus acidominimus is a member of the viridans group streptococci and is rarely pathogenic in humans, making it difficult to assess its epidemiologic and clinical significance.
We report the cases of five Han Chinese patients with invasive diseases caused by S. acidominimus over a one-year time frame. Three of the patients developed continuous fever after surgery, consisting of a successful elective laparoscopic cholecystectomy (case 1), a laparoscopic esophageal resection and gastroesophageal anastomosis (case 2), and a liver transplant in a patient with liver cancer (case 3). For these three patients, cultures of the purulent drainage material grew S. acidominimus. Case 4 concerns a 52-year-old man who developed sepsis 48 hours after hospitalization for hepatitis, liver cirrhosis and hepatitis-related glomerulonephritis. Case 5 concerns a 55-year-old woman receiving regular hemodialysis who had low-grade fever for one month. For these two patients, blood cultures grew S. acidominimus. An antimicrobial susceptibility test revealed that S. acidominimus was resistant to clindamycin and, to some degree, beta-lactam or macrolides. The S. acidominimus from the patient on hemodialysis was resistant to multiple antibiotics.
S. acidominimus is an ever-increasing cause of disease, especially in patients who are critically ill. It is showing increased resistance to antimicrobial agents, so in patients with viridans group streptococci infections, it is necessary to identify the species to improve the clinical management of S. acidominimus.
Streptococcus acidominimus is a member of viridans group streptococci (VGS) . Generally, S. acidominimus is considered to be a common bacterial pathogen in veterinary medicine. Until now, limited cases of S. acidominimus have been reported in humans, in pneumonia [2, 3], pericarditis , meningitis, otitis median  and brain abscess . Because of the poor recognition of its clinical significance in humans, identification of S. acidominimus as the causative species from the heterogeneous VGS has seldom been performed. Here, we report five cases of invasive diseases in a Han Chinese population caused by S. acidominimus over a one-year time frame.
Our patient was a 67-year-old woman who came in for an elective operation of laparoscopic cholecystectomy. Two weeks previously, she had been diagnosed with choledocholithiasis and acute cholecystitis. Sonography and computed tomography confirmed the diagnosis. She received an emergency endoscopic retrograde cholangiopancreatography with insertion of a plastic stent (8.5F × 8.0cm) and antibiotics treatment. After that, her symptoms relieved gradually.
Her cholecystectomy was successful and after the operation she was treated with intravenous cefmetazole sodium (2g,bid). However, she then developed a continuous fever. Abdominal computed tomography one week after the surgery showed accumulated fluid in her gallbladder fossa. A catheter was used to drain the fluid and the purulent drainage material was sent for culture and cytology analysis. It grew S. acidominimus, identified through the Gram-positive cocci and presence of alpha hemolysis. Based on an antibiotics sensitivity test, levofloxacin (2.4g, qid) was started intravenously (Table 1). A pathology analysis revealed Rokitansky-Aschoff sinuses with chronic cholecystitis and choledocholithiasis. Our patient was discharged uneventfully 10 days later. A follow-up visit at four weeks revealed no infection.
A 60-year-old man underwent a chest laparoscopic esophageal resection, gastroesophageal anastomosis and jejunostomy under general anesthesia in our hospital because of esophageal squamous cell carcinoma. The operation was uneventful. After the operation, he had persistent fever. A blood test on the third postoperative day showed a white blood cell count of 15,800 cells/μL with 90.2% neutrophils. There was purulent drainage material, which showed Gram-positive cocci with alpha hemolysis. A culture grew S. acidominimus. Intravenous amoxicillin-sulbactam (3g, twice daily) was started for seven days (Table 1). He recovered and was discharged one month later. No recurrent infection was identified at a four-week follow-up visit.
A 63-year-old woman received a liver transplant after receiving a diagnosis of liver cancer one and a half years’ previously. A pathology analysis revealed cholangiocarcinoma of her whole liver, with tumor thrombus and a large area of tissue necrosis in the right branch of her hepatic portal vein. After the operation, our patient presented with continuous fever. A blood test showed normal liver and kidney functions and hepatitis virus markers were all negative. Results of a coagulation test were within the normal range. At six weeks post-operation, her white blood cell count increased to 16,200 cells/μL with 80.2% neutrophils. A chest X-ray and upper abdominal computed tomography showed a subphrenic abscess and segmental lung atelectasis. After surgical drainage, the purulent material was sent for culture, which grew S. acidominimus. Our patient received levofloxacin (2.4g, qid) for six days (Table 1). She recovered and was discharged at eight weeks post-operation. No recurrent infection was present at a four-week follow-up visit.
A 52-year-old man was admitted to our hospital because of hematuria and proteinuria of one month’s duration. He had a long history of hepatitis and decompensated liver cirrhosis with recurrent esophageal and gastric visceral bleeding. A blood test showed moderate anemia. Urine analysis showed protein, red blood cells, and a 24-hour protein measurement of 0.74g to 1.71g. His erythrocyte sedimentation rate and liver and kidney functions were all within normal ranges. He was diagnosed with hepatitis-related glomerulonephritis. Forty-eight hours after his admission, he presented with high fever, abdominal pain and vomiting. A physical examination showed abdominal tenderness and guarding, and decreased intestinal sound. An abdominal X-ray showed incomplete intestinal obstruction. A blood sample was immediately sent for culture and grew S. acidominimus. According to a susceptibility test, vancomycin (0.5g, bid) and levofloxacin (0.2g, bid) were initiated. One week later, he had made an uneventful clinical recovery, and was discharged after nine days of hospitalization. Follow-up at four weeks showed no recurrent infection.
A 55-year-old woman was transferred to our hospital because of constant fever for one month’s duration. She had been under maintenance of hemodialysis for five years due to adult polycystic kidney disease and chronic renal failure. She had moderate anemia. On admission her white blood cell count was 9000 cells/μL with 74.5% neutrophils. A chest X-ray showed nothing of note. A blood culture was performed immediately after admission. It revealed a mixed infection of S. acidominimus with Enterococcus faecalis using a BD PhoenixSpec™ Calibrator Kit analysis (Becton, Dickinson and Company, Arizona, USA).
According to a susceptibility test, she was treated with vancomycin (0.5g, four times a day) and cefminox (1g, twice a day) for seven days. Her temperature returned to normal. She was discharged after 10 days of hospitalization. A follow-up at six weeks showed no recurrent infection.
S. acidominimus is a member of VGS. Previously, the precise species of VGS has not routinely been identified. To the best of our knowledge, to date there have only been seven cases of S. acidominimus reported in humans (Table 2). With the advent of automated identification systems, it has become much easier to identify VGS to the species level. In the current observational study, we report five cases of infection caused by S. acidominimus in a Chinese population, which clearly merits special attention.
None of our five patients had a history of pet or animal exposure or work exposure to animals or cattle. The current five cases had some clinical characteristics that were distinct from the previously reported seven cases of S. acidominimus (Table 2). The previous seven patients acquired the S. acidominimus in a community environment. Their age ranged from 12 to 80 years. Three of them (42.8%) were previously in excellent health. And no mixed infection was observed. In our five cases, the average age was 59.4 years (from 52 to 67). All had severe underlying diseases, and four of them had nosocomial infections (post-surgery). One patient was distinct in that she was on long-term maintenance hemodialysis, and developed sepsis with an undetermined infectious locus. She also had a mixed infection with E. faecalis. These data therefore suggest that S. acidominimus is causing increasingly nosocomial invasive diseases, especially in patients with severe underlying diseases.
There was also a great difference in the antimicrobial susceptibility test (Table 1). S. acidominimus has generally been believed to be sensitive to beta-lactam , as observed in the previous seven cases. However, in our five cases, there was increased resistance to beta-lactams, with two out of five being resistant. Additionally, compared to the zero resistance to macrolides in the previous cases, one of our patients was resistant. Further, the organisms in all five patients were resistant to clindamycin. The resistance of S. acidominimus to antibiotics warrants the accurate identification of the responsible species from the VGS to allow appropriate antibiotic treatment.
Finally, our patient on hemodialysis had a mixed infection of S. acidominimus and E. faecalis, a Gram-positive bacterium and member of the Lancefield group D streptococci . Currently, E. faecalis is considered the second to third most common organism responsible for bacteremia in patients on chronic hemodialysis [11, 12]. The infection of S. acidominimus mixed with E. faecalis was especially resistant to multiple antibiotics including beta-lactams, macrolides, and clindamycin. We were unable to find any reported cases of S. acidominimus infection in a patient on hemodialysis. Therefore, to the best of our knowledge, our study represents the first such report and highlights the possibility of increased resistance in the case of a mixed infection.
S. acidominimus is an ever-increasing cause of disease, especially in patients who are critically ill. It is showing increased resistance to antimicrobial agents, so in patients with VGS infections, it is necessary to identify the species to improve the clinical management of S. acidominimus.
Written informed consent was obtained from the patients for publication of this manuscript. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Viridans group streptococci.
Siegman-Igra Y, Azmon Y, Schwartz D: Milleri group streptococcus–a stepchild in the viridans family. Eur J Clin Microbiol. 2012, 3: 2453-2459.
Baker L, Carlson R: Streptococcus acidominimus isolated from a multiloculated empyema in a critically ill adult man with pneumonia: case report and review of literature. Heart Lung. 2008, 37: 308-310. 10.1016/j.hrtlng.2007.08.002.
Akaike T, Suga M, Ando M, Ando Y, Araki S, Fujise R: Streptococcus acidominimus infections in a human. Jpn J Med. 1988, 27: 317-320. 10.2169/internalmedicine1962.27.317.
Brachlow A, Awadallah S, Chatterjee A: Endocarditis due to Streptococcus acidominimus. Pediatr Cardiol. 2003, 24: 161-163. 10.1007/s00246-002-0253-x.
Finkelstein Y, Marcus N, Mosseri R, Bar-Sever Z, Garty BZ: Streptococcus acidominimus infection in a child causing Gradenigo syndrome. Int J Pediatr Otorhi. 2003, 67: 815-817. 10.1016/S0165-5876(03)00088-0.
Cone LA, Etebar S, Waterbor RB: Brain abscess due to Streptococcus acidominimus: first case report. Surg Neurol. 2007, 67: 296-297. 10.1016/j.surneu.2006.06.062.
Zhang GL, Qiang QJ: Massive ascites due to Streptococcus acidominimus: report of one case. J First Mil Med Univ. 2004, 24: 545-
Dalal A, Urban C: Human Infections Due to Streptococcus acidominimus. Infect Dis Clin Pract. 2008, 16: 283-284. 10.1097/IPC.0b013e31816fd608.
Maeda Y, Coulter WA, Goldsmith CE, Cherie Millar B, Moore JE: UV-C-irradiation sublethal stress does not alter antibiotic susceptibility of the viridans group streptococci to beta-lactam, macrolide, and fluoroquinolone antibiotic agents. J Investig Clin Dent. 2012, 3: 198-202. 10.1111/j.2041-1626.2011.00100.x.
Reffuveille F, Leneveu C, Chevalier S, Auffray Y, Rince A: Lipoproteins of Enterococcus faecalis: bioinformatic identification, expression analysis and relation to virulence. Microbiology. 2011, 157: 3001-3013. 10.1099/mic.0.053314-0.
Snyder GM, D’Agata EM: Novel antimicrobial-resistant bacteria among patients requiring chronic hemodialysis. Curr Opin Nephrol Hypertens. 2012, 21: 211-215. 10.1097/MNH.0b013e328350089b.
Li PK, Chow KM: Infectious complications in dialysis–epidemiology and outcomes. Nat Rev Nephrol. 2012, 8: 77-88.
This work was supported by the General Program (Key Program, Major Research Plan) of National Natural Science Foundation of China (81230007) and National Natural Science Foundation of China (81200147, 81200185).
The authors declare that they have no competing interests.
CW, YZ and JG conceived of the study and drafted the manuscript. BL, YG and LZ read the previous relevant cases, collected the data, and performed the analysis. All authors read and approved the final manuscript.
Chaoneng Wu, Buqing Liang contributed equally to this work.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Wu, C., Liang, B., Gong, Y. et al. Streptococcus acidominimus causing invasive disease in humans: a case series. J Med Case Reports 8, 57 (2014). https://doi.org/10.1186/1752-1947-8-57
- Case series
- Streptococcus acidominimus
- Viridans group streptococci